Get started
NINGXIA ZHONGKE BIOTECHNOLOGY CO LTNN

NINGXIA ZHONGKE BIOTECHNOLOGY CO LT

3.73CNYD
+0.18+5.07%
At close at Mar 7, 09:09 GMT
CNY
No trades
See on Supercharts
Overview
Financials
News Discussions Technicals Seasonals

600165 fundamentals

Key facts

Market capitalization‪2.55 B‬CNY
Dividend yield (indicated)—
Price to earnings Ratio (TTM)—
Basic EPS (TTM)−1.06CNY
Founded1998
Employees (FY)731
CEORui Chen
Websitexinrihengli.com
About

Ningxia Zhongke Biotechnology Co., Ltd. engages in the production, sales of activated carbon products and lauric acid, stem cell preparation, trade, storage and other business. It operates through Licensed and General Projects. The company was founded on May 14,1998 and is headquartered in Yinchuan, China.

Ownership
‪‪684.88 M‬‬
Free Float shares
‪‪421.78 M‬‬ (61.58%)
Closely held shares
‪‪263.11 M‬‬ (38.42%)
Free Float shares
‪‪421.78 M‬‬ (61.58%)
Closely held shares
‪‪263.11 M‬‬ (38.42%)
Capital structure
Market cap
‪‪2.55 B‬‬
Debt
‪‪1.21 B‬‬
Minority interest
‪‪194.74 M‬‬
Cash & equivalents
‪‪96.76 M‬‬
Enterprise value
‪‪3.86 B‬‬

Valuation

Fundamental metrics to determine fair value of the stock

Summary
‪‪2.55 B‬‬
Price to earning ratio (P/E)
—
Price to sales ratio (P/S)
8.28x
Market Cap
Net income
Revenue
Price to earning ratio (P/E)
—
Price to sales ratio (P/S)
8.28x
Valuation ratios
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪0.00‬
‪3.00‬
‪6.00‬
‪9.00‬
‪12.00‬
P/S

Growth and Profitability

Company’s recent performance and margins

Performance
‪−675%‬
‪−525%‬
‪−375%‬
‪−225%‬
‪−75%‬
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪‪−390.00 M‬‬
‪‪−260.00 M‬‬
‪‪−130.00 M‬‬
‪0.00‬
‪‪130.00 M‬‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪‪−80.00 M‬‬
‪‪−40.00 M‬‬
‪0.00‬
‪‪40.00 M‬‬
‪‪80.00 M‬‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪‪−80.00 M‬‬
‪‪−40.00 M‬‬
‪0.00‬
‪‪40.00 M‬‬
‪‪80.00 M‬‬

Revenue breakdown

Revenue streams and regions a business earns money from

By source/business
Period: 2023
Activated Carbon
Long Chain Dicarboxylic Acid
By country
Period: 2023
China
Abroad

Estimates

Revenue and Earnings forecasts and estimates accuracy

Revenue
‪0.00‬
‪‪450.00 M‬‬
‪‪900.00 M‬‬
‪‪1.35 B‬‬
‪‪1.80 B‬‬
Estimate
Earnings
Next:—
‪0.00‬
‪0.06‬
‪0.12‬
‪0.18‬
‪0.24‬
Estimate

Dividends

Dividend yield, history and sustainability

600165 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company

Debt level and coverage
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪‪−600.00 M‬‬
‪0.00‬
‪‪600.00 M‬‬
‪‪1.20 B‬‬
‪‪1.80 B‬‬
Debt
Free cash flow
Cash & equivalents
Financial position analysis
Short term
Long term
‪0.00‬
‪‪500.00 M‬‬
‪‪1.00 B‬‬
‪‪1.50 B‬‬
‪‪2.00 B‬‬
Assets
Liabilities